Groupe Athena, Inc. Posts 2nd Quarter Results
January 28 2015 - 12:54PM
eTeligis
MUMBAI(Eteligis Inc.)
MUMBAI, India, via ETELIGIS INC., 01/28/2015 - - Groupe Athena,
Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues
of $19,005,429 for the period ending December 31, 2014, an increase
of $1,043,977 over the same period in 2013. Operating income before
Depreciation and Amortization was $2,845,789 and reflects a
Research and Development charge of $428,659. Net income for the
period was $1,859,924 or $.04 per share.
The company is pleased to say that total assets including cash
and reserves are now $24,685,730 which is more than $.52 per share
and liabilities remain low at $59,138.
The Indian pharmaceutical industry is increasingly focusing on
exports to the United States and GATA is well positioned to help
them get their products approved by the FDA for sales in the US.
All of these are potential clients and the Company believes it has
an advantage over competitors due to the facilities based in India,
and their ability to deliver quick feedback to clients that could
result in expedited order generation. With recent additions to
equipment, the company will continue to take on additional
contracts and continue to anticipate further growth.
The company also continues to negotiate with several Indian drug
companies for the manufacture of additional generic pharmaceuticals
with intent to market in the United Kingdom under the anticipated
license they are in the process of applying for.
About Groupe Athena, Inc.
Groupe Athena, Inc. was incorporated in June 2008 and began
operations on July 1 of that year. The company is a research and
testing organization and helps various pharmaceutical and medical
products and devices companies in India and Southeast Asia to get
regulatory approvals and facilitate exports of their products to
the United States. The Company accomplishes this by assisting
clients from concept through development, providing consultation on
regulatory requirements, filings and processes.
The company has a research and marketing facility in India that
employs 21 consultants and marketing personnel and is working
towards aggressively expanding its presence in the Indian
pharmaceutical industry. The Company's web address is
www.groupeathena.com.
To review the complete quarterly report please go to
www.otcmarkets.com/stock/GATA/quote and click on "Financials".
Safe Harbor Statement
Certain statements set forth in this press release constitute
"forward-looking statements." Forward-looking statements include,
without limitation, any statement that may predict, forecast,
indicate, or imply future results, performance or achievements, and
may contain the words "estimate", "project", "intend", "forecast",
"anticipate", "plan", "planning", "expect", "believe", "will
likely", "should", "could", "would", "may" or words or expressions
of similar meaning. Such statements are not guarantees of future
performance and are subject to risks and uncertainties that could
cause the company's actual results and financial position to differ
materially from those included within the forward-looking
statements. Forward-looking statements involve risks and
uncertainties, including those relating to the Company's ability to
grow its business. Actual results may differ materially from the
results predicted and reported results should not be considered as
an indication of future performance. The potential risks and
uncertainties include, among others, the Company's limited
operating history, the limited financial resources, domestic or
global economic conditions -- activities of competitors and the
presence of new or additional competition and conditions of equity
markets.
CONTACT:
Paul Cornell
Cornellpaul6@gmail.com
SOURCE: Groupe Athena, Inc.
Associated Documentation:
http://www.eteligis.com/ViewSubmission.aspx?submissionRequest=27992
- Link to submission on http://www.eteligis.com